
ALT $SOTK Sono-Tek Corporation (Nasdaq: SOTK) reported strong financial results for Q1 FY2026, ended May 31, 2025, marking its fifth consecutive quarter with revenue over $5 million, driven by the successful completion of a $2.95 million order for the advanced solar market. Gross margins expanded to 52%, fueled by the high average selling price (ASP) order, and operating income rose 103% year-over-year. The company expects continued revenue growth and profitability through the first half of FY2026. However, its full-year outlook remains measured due to potential impacts from policy changes in the newly enacted budget legislation. Sono-Tek remains focused on high-margin, high-tech applications and expanding its presence in clean tech sectors, such as solar.

ALT $ACON Aclarion, Inc. (Nasdaq: ACON, ACONW), a healthcare technology company pioneering AI-driven diagnostics for chronic low back pain, has signed a commercial agreement with the Spine Institute of Louisiana (SIL) in Shreveport. This milestone brings Aclarion’s flagship solution, Nociscan, to one of the nation's most respected spine centers. By combining advanced biomarkers with proprietary AI algorithms, Aclarion empowers physicians to pinpoint pain sources with precision, enhancing treatment outcomes. The partnership underscores Aclarion’s national expansion and commitment to transforming spine care through innovation. Key Highlights: Nociscan now available at the Spine Institute of Louisiana. Expands Aclarion’s AI-powered diagnostic footprint in the U.S.
























